Heart rate monitoring to predict biologic therapy response in IBD
Part of Brain & nervous system, Digestive system, Mental health clinical trials.
This study tests whether a wearable heart rate monitor can help predict how well biologic medications work for people with Crohn's disease or ulcerative colitis. If you are starting infliximab or vedolizumab for the first time, you may be eligible.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with ulcerative colitis or Crohn's disease for at least 3 months.
- You are starting infliximab or vedolizumab (biologics) for the first time.
- You can wear a small heart rate monitor device and agree to the study.
- You are not taking more than one biologic at the same time.
- You have not had IBD-related surgery in the last 4 weeks or plan any during the study.
- You do not have severe anxiety or depression that is not controlled, or take certain heart medications that cannot stay at a stable dose.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies whether training your body to control heart-rate patterns (biofeedback) can reduce symptoms during an ulcerative colitis flare. It may help by targeting the body’s stress and heart rhythm signals without directly changing inflammation.
This study tests whether a non-invasive device (like a wearable or smartphone app) can measure inflammation in people with active IBD. It aims to make monitoring easier and less uncomfortable than traditional methods.
This study looks at different ways to measure the amount of biologic drugs in your blood. It is for people with inflammatory bowel disease who are about to start a new biologic therapy or have never taken one before.
This study tests whether people with inflammatory bowel disease (IBD) can be safely monitored from home instead of visiting the hospital every few months. It uses a smartphone app and home tests to check your condition, with fewer in-person visits.
This study looks at cardiovascular risks in people with inflammatory bowel disease (IBD), like ulcerative colitis or Crohn's disease. It may help understand how IBD affects heart health.
This study uses a smartphone app and activity tracker to monitor how people with Crohn's disease, ulcerative colitis, or unspecified IBD feel day to day. It may help doctors better understand and manage your condition through digital health data.
Hear when a new Inflammatory Bowel Diseases trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.